Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Work In Process (2022 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Work In Process for 4 consecutive years, with $102000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Work In Process fell 42.37% to $102000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $102000.0, a 42.37% decrease, with the full-year FY2025 number at $102000.0, down 42.37% from a year prior.
  • Work In Process was $102000.0 for Q4 2025 at Ekso Bionics Holdings, down from $324000.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $751000.0 in Q2 2023 to a low of $102000.0 in Q4 2025.
  • A 4-year average of $332833.3 and a median of $310000.0 in 2024 define the central range for Work In Process.
  • Peak YoY movement for Work In Process: plummeted 71.11% in 2024, then soared 38.25% in 2025.
  • Ekso Bionics Holdings' Work In Process stood at $487000.0 in 2022, then tumbled by 40.45% to $290000.0 in 2023, then crashed by 38.97% to $177000.0 in 2024, then plummeted by 42.37% to $102000.0 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Work In Process are $102000.0 (Q4 2025), $324000.0 (Q3 2025), and $300000.0 (Q2 2025).